Tuberculosis (TB) patients in Morocco are facing dual challenges: the suffering from the disease itself, which particularly targets the most vulnerable groups in society, and the increasing difficulties in obtaining necessary medications for treatment.
According to health sources in the Fez-Meknes region, there has been a severe shortage of TB medicines in many health centers across various provinces of the kingdom, especially in this region. The danger of this shortage lies in the fact that these medicines are dispensed free of charge and are not available in private pharmacies, leading to treatment interruption for many patients.
It is worth noting that continuity of treatment is vital to avoid deaths and prevent the spread of drug-resistant TB strains. Sources have confirmed that the suspension of TB medicine supply to health centers has been ongoing for some time, while the disease continues to spread at an increasing rate in the country due to multiple social, health, and epidemiological factors.
In a related context, a delegation from the Global Fund to Fight AIDS, Tuberculosis and Malaria, based in Geneva, recently visited the Regional Health Directorate in the Fez-Meknes region. The visit included inspecting TB and respiratory disease diagnostic centers, aiming to evaluate the TB control program and its relationship with HIV/AIDS.
This crisis highlights the urgent need to strengthen TB control efforts in Morocco and ensure continuous provision of necessary medicines to patients, especially in light of the health and social challenges facing the country. It also underscores the importance of international cooperation in public health to address these challenges.